Hepatitis C, Chronic
Concept
Vocabulary Service
Overview
subject area of
-
A Patient with a Leg Rash, Pedal Edema, Renal Failure, and Thrombocytopenia Academic Article
-
A randomized study of alpha-interferon plus ribavirin for 6 months or 12 months for the treatment of chronic hepatitis C in patients with bleeding disorders Academic Article
-
Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database Academic Article
-
Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus Academic Article
-
Bone mineral density in haemophilia patients Academic Article
-
Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis Academic Article
-
Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alfa-2a plus ribavirin Academic Article
-
Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study Academic Article
-
Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for treatment of hepatitis C virus genotype 3 infection in Canada Academic Article
-
Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis Academic Article
-
Efficacy and Safety of Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin for the Treatment of Chronic Hepatitis C in Children and Adolescents: A Systematic Review and Meta-analysis Academic Article
-
Efficacy and safety of a two‐drug direct‐acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6 Academic Article
-
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials Academic Article
-
Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus Academic Article
-
Estimating chronic hepatitis C prognosis using transient elastography‐based liver stiffness: A systematic review and meta‐analysis Academic Article
-
Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update Academic Article
-
Expanding Access to Treatment for Hepatitis C in Resource-Limited Settings: Lessons From HIV/AIDS Academic Article
-
Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts Academic Article
-
Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression Academic Article
-
HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy Academic Article
-
Health care costs associated with hepatitis C virus infection in First Nations populations in Ontario: a retrospective matched cohort study Academic Article
-
Health state utilities associated with attributes of treatments for hepatitis C Academic Article
-
Hepatitis C Virus Testing of Persons Born During 1945–1965: Recommendations From the Centers for Disease Control and Prevention Academic Article
-
Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants Academic Article
-
How much management is necessary? Sustaining the benefit of achieving a sustained virologic response to hepatitis C Academic Article
-
IL28B polymorphism (rs12979860) associated with clearance of HCV infection in Poland: Systematic review of its prevalence in chronic hepatitis C patients and general population frequency Academic Article
-
Impact of Asian Race on Response to Combination Therapy With Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Academic Article
-
Increased Eligibility for Treatment of Chronic Hepatitis C Infection with Shortened Duration of Therapy: Implications for Access to Care and Elimination Strategies in Canada Academic Article
-
Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review Academic Article
-
Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study Academic Article
-
Letter to the Editor Academic Article
-
Long Term Follow-Up of Patients with Chronic Hepatitis C Treated with Alpha Interferon Academic Article
-
Marijuana Use in Hepatitis C Infection does not Affect Liver Biopsy Histology or Treatment Outcomes Academic Article
-
Missed Opportunities for Hepatocellular Carcinoma Screening in an HIV/Hepatitis C Virus-Coinfected Cohort Academic Article
-
Network meta-analysis of direct-acting antivirals in combination with peginterferon–ribavirin for previously untreated patients with hepatitis C genotype 1 infection Academic Article
-
Oral prostaglandin (PGE2) therapy for chronic viral hepatitis B and C Academic Article
-
Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada) Academic Article
-
Paranoid psychosis and cognitive impairment associated with hepatitis C antiviral therapy Academic Article
-
Peginterferon Plus Ribavirin for Chronic Hepatitis C in Patients With Human Immunodeficiency Virus Academic Article
-
Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials Academic Article
-
Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C Academic Article
-
Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C Academic Article
-
Prevalence of Hepatitis C Virus Infection in a Surgical Population of Southeast China: A Large-Scale Multicenter Study Academic Article
-
Prevalence of insulin resistance in chronic hepatitis C genotype 1 and 3 patients Academic Article
-
Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C–Coinfected Persons Academic Article
-
Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies Academic Article
-
Real-world impact of direct acting antiviral therapy on health-related quality of life in HIV/Hepatitis C co-infected individuals Academic Article
-
Recommendations for the identification of chronic hepatitis C virus (HCV) infection among persons born during 1945 through 1965 Academic Article
-
Reply to: “Real-world experience of serial serum levels of GS-331007 in chronic hepatitis C hemodialysis patients during and after sofosbuvir/velpatasvir therapy” Academic Article
-
Retreatment with Pegylated Interferon Alpha-2a and Ribavirin in Patients with Chronic Hepatitis C Who Have Relapsed or Not Responded to a First Course of Pegylated Interferon-Based Therapy Academic Article
-
Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry Academic Article
-
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis Academic Article
-
Suicide risk in hepatitis C and during interferon-alpha therapy: a review and clinical update Academic Article
-
The health impact of delaying direct‐acting antiviral treatment for chronic hepatitis C: A decision‐analytic approach Academic Article
-
The novel immunoregulatory molecule FGL2: A potential biomarker for severity of chronic hepatitis C virus infection Academic Article
-
Treatment responses in Asians and Caucasians with chronic hepatitis C infection Academic Article